openPR Logo
Press release

Presbyopia Therapeutics Segmental Analysis by Therapeutics, Diagnostics, Patient, Drugs Policy & Regulatory Landscape

01-23-2018 09:27 AM CET | Health & Medicine

Press release from: P&S Market Research

Presbyopia Therapeutics Segmental Analysis by Therapeutics,

The study analyzed that the presbyopia therapeutics pipeline comprises nine drug candidates in different stages of development. Presbyopia is an age-related eye condition that causes visual impairment gradually. The disease has been described as "an irreversible optical failure, an unexplained evolutionary blunder that comes as a psychologic shock”. Though not incapacitating if corrected, presbyopia without optical correction results in an inability to perform once-effortless near tasks at a customary working distance without experiencing visual symptoms. The disease can result from the gradual decrease in the amplitude of accommodation.

Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/presbyopia-therapeutics-pipeline-analysis

Various pharmaceutical companies such as Novartis AG, Allergan Plc., Janssen Global Services LLC, and Acucela Inc. are engaged in the development drug candidates for the treatment of presbyopia.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/presbyopia-therapeutics-pipeline-analysis/report-sample

Various pharmaceutical companies are developing drug candidates for the treatment of presbyopia, which have shown positive results in different stages of development. For instance, UNR844 showed a statistically significant difference to placebo in distant corrected near vision at all time points measured (from day 8) in the Phase I/II, placebo-controlled, proof-of-concept study carried out in 50 patients daily for 90 days with topical UNR844 and in 25 patients with placebo. At day 90, 82% of participants treated with UNR844 had 20/40 near vision (or 0.30 LogMAR) versus 48% in the placebo group. Near vision of 20/40 allows the majority of near vision tasks in most people.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=presbyopia-therapeutics-pipeline-analysis

Various pharmaceutical companies are involved in manufacturing drugs for the treatment of presbyopia. In January 2017, Alcon, the eye care division of Novartis AG, launched AcrySof IQ PanOptix Toric intraocular lens for presbyopia. The launch of the AcrySof IQ PanOptix Toric intraocular lens is a significant achievement in presbyopia treatment. Most of the drug candidates have received or have filed for patent covering a novel mechanism for the treatment of presbyopia.

Some of the key players developing Novartis AG, Allergan Plc, and ORASIS Pharmaceuticals Ltd.

Presbyopia pipeline analysis
• By Phase
• By Molecule Type
• By Route of Administration
• By Company

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Presbyopia Therapeutics Segmental Analysis by Therapeutics, Diagnostics, Patient, Drugs Policy & Regulatory Landscape here

News-ID: 912671 • Views:

More Releases from P&S Market Research

Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Drivers and Opportunities by 2023
Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Driv …
The global smart cities market is growing at a CAGR above 20% during 2018 - 2023 and will reach $2578.0 billion by 2023. Due to significant growth in automation technologies such as internet of things (IoT) and adoption of cloud based technologies, the global smart cities market is gaining huge traction. In addition, effective city asset management for public welfare, substantial operational cost savings, and automated public data generation applications
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
The global sports food market is expected to grow at a CAGR of 9.2% in terms of value during 2016 - 2022. Among the various types, the energy bars segment accounted for the largest share (71.5%) in the global sports food market in 2015. Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-food-market/report-sample The manufacturers are trying to bring about products with the best blend of taste and healthy ingredients. They have started to
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand Forecast to 2022
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand …
The global sports nutrition market is expected to grow at a CAGR of 8.4% in terms of value during 2016 - 2022. Among the various types, the sports drinks segment accounted for largest share (61.4%) in the global sports nutrition market in 2015. Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-nutrition-market/report-sample The increasing health concerns, such as obesity and awareness of physical appearances among all consumers groups is driving the demand for sports
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technological Advancements
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technolo …
The global orthopedic trauma devices market is growing due to the increasing frequency of fractures, along with the growth of aging population. The advantageous features posed by orthopedic trauma devices, such as internal and external fixators to set a fracture, and in repositioning of bone fragments into their normal alignment are also driving the growth of the market worldwide. Furthermore, the internal fixators have reduced the hospital stays, reduced the

All 5 Releases


More Releases for Presbyopia

Presbyopia Market 2020-2027 Sets the Table for Continued Growth || Top Growing C …
A transparent research method has been accomplished with the right tools and techniques to make this Presbyopia Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter's Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions, agreements, joint
Global Presbyopia Correction Devices Market 2019 - AcuFocus, Refocus, Presbia
This new report by Eon Market Research, titled “Global Presbyopia Correction Devices Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Presbyopia Correction Devices industry at a global as well as regional and country level. Key facts analyzed in this report include the Presbyopia Correction Devices market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses
Presbyopia Market Growth And Restrain Factors Analysis H1 2017
Overview Presbyopia is an eye condition in which eye slowly loses the ability to focus quickly on objects that are close. Presbyopia happens in people as they age. Signs and symptoms include headaches, eyestrain, difficulty reading small print and fatigue. Risk factors include anemia, diabetes, cardiovascular disease, hyperopia, multiple sclerosis, myasthenia gravis and eye trauma.  Click here for sample report @ http://www.wiseguyreports.com/sample-request/1555348-presbyopia-pipeline-review-h1-2017 Report Highlights The Presbyopia (Ophthalmology) pipeline guide also reviews of key players
Presbyopia Therapeutics Pipeline Analysis 2018
Presbyopia Pipeline Analysis The study analyzed that the presbyopia therapeutics pipeline comprises nine drug candidates in different stages of development. Presbyopia is an age-related eye condition that causes visual impairment gradually. The disease has been described as "an irreversible optical failure, an unexplained evolutionary blunder that comes as a psychologic shock”. Though not incapacitating if corrected, presbyopia without optical correction results in an inability to perform once-effortless near tasks at a
Presbyopia - Pipeline Review, H2 2017 - MarketResearchReports.
"The Report Presbyopia - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Presbyopia - Pipeline Review, H2 2017, provides an overview of the Presbyopia (Ophthalmology) pipeline landscape. Presbyopia is an eye condition in which eye slowly loses the ability to focus quickly on objects that are close. Presbyopia happens
Presbyopia - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 30 pages on Title " Presbyopia - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Presbyopia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Presbyopia - Pipeline Review, H1 2017, provides an overview of the Presbyopia (Ophthalmology) pipeline landscape. Presbyopia is an eye condition in which eye slowly loses the ability to focus quickly